Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... in patients with previously treated GBM, including some patients who had received prior antiangiogenic therapy. A total of 46 patients in first or second relapse were enrolled and dosed with ...
2009 NOV 9 ... but do not reliably prevent recurrence. Therefore, sublesional injections of the antiangiogenic agent bevacizumab (Avastin) were given to assess the effect on disease recurrence and ...
2009 NOV 1 ... of 3,267 genes, including those of angiogenic significance, further substantiating the antiangiogenic function of Haemangin. We establish the vital roles of Haemangin in the hard tick ...
2009 NOV 16 ... assays. Endothelial cell tube formation and aorta sprouting assays were done to examine antiangiogenic effects. In vivo effects were also evaluated using HCT116 xenograft studies. A selected ...
2009 NOV 2 ... parameters. An extended new application is the evaluation of the therapeutic effect of antiangiogenic drugs on liver tumours. Novel, but already widespread, is a histologically validated ...
2009 NOV 2 ... HEMORRHAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AFTER STABILIZATION WITH ANTIANGIOGENIC THERAPY. Retina - the Journal of Retinal and Vitreous Diseases, 2009;29(8):1074-1079). ...
2009 NOV 9 ... tolerability of ABT-869 at escalating doses and its effects on biomarkers relevant for antiangiogenic activity in patients with solid malignancies. Patients with solid malignancies ...
2009 NOV 1 ... therapies are based on current concepts of molecular biology of cancer. These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent ...
2009 NOV 23 ... or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be ...
2009 NOV 1 ... (VDR) gene polymorphisms may influence the cancer risk due to their antiproliferative, antiangiogenic, antimetastatic and apoptoic effects." "The genotype and haplotype ...
2009 NOV 16 ... researchers in the United States conducted a study "To determine the impact of the antiangiogenic factor alpha 1(IV)NC1 on vascular endothelial growth factor-mediated proangiogenic ...
2009 NOV 23 ... therapeutic option, especially considering its lower cost in comparison with other antiangiogenic drugs. RETINA 29:1227-1234, 2009." Costagliola and colleagues published ...
2009 NOV 2 ... fragmentation, fibroblast growth factor type I receptor kinase inhibition, and in-vitro antiangiogenic analysis," scientists writing in the Journal of Pharmacy and Pharmacology report. ...
2009 NOV 2 ... Blood, "Angiostatin was first discovered as a plasminogen fragment with antitumor/antiangiogenic property. One of the angiostatin isoforms, that is, angiostatin 4.5 (AS4.5), consisting ...
2009 NOV 9 ... "The murine homologue of human vasohibin (mVASH1), a putative antiangiogenic protein, was investigated for its effects on in vitro and in vivo angiogenesis. Cell ...
2009 NOV 1 ... "Neoangiogenesis has been documented in small cell lung carcinoma (SCLC). In addition, antiangiogenic therapies are being tested in clinical trials that involve SCLC." ...
2009 NOV 9 ... published their study in Reproductive Sciences (Increased Circulating Levels of the Antiangiogenic Factor Endostatin in Early-Onset But Not Late-Onset Preeclampsia. Reproductive Sciences, ...
2009 NOV 16 ... SSTRs inhibits glioma cell proliferation in vivo through both direct cytotostatic and antiangiogenic effects." Barbieri and colleagues published their study in American ...
2009 NOV 23 ... phosphorylation, and this inhibitory effect was not reversed by GW9662 (10 mc M). The antiangiogenic activity of TROG correlated with suppression of VEGF-induced matrix metalloproteinase ...
